Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. (Q44247874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Ruth H Green

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Beverley Hargadon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Susan McKenna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Debbie Parker

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

9347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1715-1721

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480423%20AND%20SRC:MED&resulttype=core&format=json

Eosinophils in asthma and other allergic diseases.

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Prednisone-dependent asthma: inflammatory indices in induced sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Changes in sputum eosinophils predict loss of asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

The use of induced sputum to investigate airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Minimisation: the platinum standard for trials?. Randomisation doesn't guarantee similarity of groups; minimisation does

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Non-eosinophilic cor ticosteroid unresponsive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

How should cost data in pragmatic randomised trials be analysed?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Risk factors and costs associated with an asthma attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Mast-cell infiltration of airway smooth muscle in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Airway structure and inflammatory cells in fatal attacks of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Differences between asthma exacerbations and poor asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021

Impaired Perception of Dyspnea in Patients with Severe Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911679-5

7 January 2021